CAH enters fiscal 2027 with Pharma profit growth, emerging growth engines and efficiency gains offsetting revenue headwinds.

Cardinal Health (CAH) closed the most recent trading day at $233.12, moving +2.11% from the previous trading session.

Park National Corp OH trimmed its position in shares of Cardinal Health, Inc. (NYSE: CAH) by 8.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 52,115 shares of the company's stock after selling 4,578 shares during the

MassMutual Private Wealth and Trust FSB increased its stake in Cardinal Health, Inc. (NYSE: CAH) by 6,447.7% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 108,364 shares of the company's stock after purchasing an additional 106,709 shares during

Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.

DUBLIN, Ohio, Oct. 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuation of Cardinal Health's current scope of distribution services. "We value our long-standing partnership with CVS Health and look forward to continuing to bring our best-in-class capabilities together to serve their customers," stated Jason Hollar, CEO of Cardinal Health.

DUBLIN, Ohio, Oct. 1, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2027 on November 5, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m.

Cardinal Health remains a Buy, driven by robust FY2026 results, strong cash flow, and credible FY2027 guidance. CAH delivered 14% revenue growth, 20% gross margin expansion, and doubled free cash flow, despite ongoing thin margins and higher current liabilities. FY2027 guidance targets 13-15% non-GAAP EPS growth, with profit improvement expected from both Pharmaceutical and Specialty Solutions and higher-margin 'Other' segments.

At-Home Solutions is powering CAH???s growth strategy as investments, acquisitions and technology help it scale in home-based healthcare.

Cardinal Health (CAH) closed at $220.22 in the latest trading session, marking a -1.08% move from the prior day.